Genelux (GNLX) Change in Accured Expenses (2022 - 2026)

Genelux's Change in Accured Expenses history runs 5 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 55.37% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was -$594000.0, a 117.05% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 million, down 156.26% from the prior year.
• Change in Accured Expenses climbed to $1.7 million in Q1 2026 per GNLX's latest filing, from $374000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $1.8 million in Q4 2024 and bottomed at -$2.0 million in Q3 2025.
• The 5-year median for Change in Accured Expenses is $60000.0 (2022), against an average of $196357.1.
• Across the five-year window, Change in Accured Expenses plunged 2909.09% in 2024 and jumped 634.93% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at -$95000.0 in 2022, then surged by 76.84% to -$22000.0 in 2023, then surged by 8354.55% to $1.8 million in 2024, then sank by 79.41% to $374000.0 in 2025, then jumped by 364.44% to $1.7 million in 2026.
• Per Business Quant, the three latest GNLX Change in Accured Expenses figures stand at $1.7 million (Q1 2026), $374000.0 (Q4 2025), and -$2.0 million (Q3 2025).